Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

K

KLRS

Kalaris Therapeutics Inc

4.02

Aug 04 • 9:59 AM ET -0.03 (-0.74%)

Healthcare Biotechnology USA Micro NASD

Peers: AARD AGEN CGTX CNTB GALT IMUX KZIA NTHI SPRO VRCA

| Held by: VTI VXF IWC BUSM DCOR DFAC

Scroll to Statements

Index	-
Market Cap	87.75M
Enterprise Value	-8.06M
Income	-44.10M
Sales	0.00M
Book/sh	2.98
Cash/sh	4.45
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	20
IPO	Jul 30, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.35
P/C	0.90
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	12.14
Current Ratio	12.14
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-2.14
EPS next Y	-1.63
EPS next Q	-0.49
EPS this Y	27.64%
EPS next Y	21.14%
EPS next 5Y	7.15%
EPS past 3/5Y	61.69% 45.59%
Sales past 3/5Y	- -
EPS Y/Y TTM	73.91%
Sales Y/Y TTM	-
EPS Q/Q	81.81%
Sales Q/Q	-
Earnings	May 12 BMO
EPS/Sales Surpr.	12.10% -

Insider Own	64.38%
Insider Trans	5.42%
Inst Own	20.93%
Inst Trans	1.31%
ROA	-41.43%
ROE	-66.60%
ROIC	-63.31%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-1.42%
SMA50	-8.09%
SMA200	-38.48%
Trades

Shs Outstand	22.99M
Shs Float	8.48M
Short Float	6.13%
Short Ratio	1.95
Short Interest	0.52M
52W High	11.88 -66.16%
52W Low	2.14 87.85%
Volatility	12.04% 11.36%
ATR (14)	0.41
RSI (14)	48.35
Beta	0.19
Rel Volume	0.15
Avg Volume	267.11K
Volume	4,949

Perf Week	20.36%
Perf Month	-13.55%
Perf Quarter	-27.31%
Perf Half Y	-55.87%
Perf YTD	-52.37%
Perf Year	55.81%
Perf 3Y	-94.38%
Perf 5Y	-99.11%
Perf 10Y	-
Recom	1.22
Target Price	18.75
Prev Close	4.05
Price	4.02
Change	-0.74%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)